No Data
No Data
No Data
No Data
No Data
Biote Schedules First Quarter 2024 Financial Results Release and Conference Call
biote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced the
BusinesswireApr 24 04:05
B. Riley Ups Price Target on Biote to $10 From $9, Maintains Buy Rating
Biote (BTMD) has an average rating of buy and price targets ranging from $7 to $10, according to analysts polled by Capital IQ. Price: 5.6, Change: -0.15, Percent Change: -2.61
MT NewswiresApr 5 21:27
Correction: --B. Riley Lowers Bitcoin Depot's Price Target to $4 From $6, Maintains Buy Rating
(Corrected with the BTM ticker and Bitcoin Depot name in the headline.)
MT NewswiresApr 3 22:24
12 Health Care Stocks Moving In Friday's After-Market Session
GainersQilian Intl Hldg Gr (NASDAQ:QLI) shares rose 63.8% to $1.04 during Friday's after-market session. The market value of their outstanding shares is at $37.1 million. Sunshine Biopharma (NASDAQ:SB
BenzingaMar 30 04:30
Optimistic Outlook: Biote's Growth Potential and Strategic Initiatives Despite Transitional Challenges
TipRanksMar 15 09:15
Biote Corp. Releases March 2024 Investor Presentation
TipRanksMar 15 04:24
No Data
No Data